Norman DJ - Search Results

1

Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experience.

Norman DJ, Bennett WM, Cobanoglu A, Hershberger R, Hosenpud JD, Meyer MM, Misiti J, Ott G, Ratkovec R, Shihab F, et al. Norman DJ, et al. Transplant Proc. 1993 Feb;25(1 Pt 1):802-3. Transplant Proc. 1993. PMID: 8438490 No abstract available.

2

Methotrexate for the treatment of patients with multiple episodes of acute cardiac allograft rejection.

Hosenpud JD, Hershberger RE, Ratkovec RR, Hovaguimian H, Ott G, Cobanoglu A, Norman D. Hosenpud JD, et al. J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 1):739-45. J Heart Lung Transplant. 1992. PMID: 1498141

3

OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low doses.

Norman DJ, Barry JM, Bennett WM, Munson JL, Meyer M, Henell K, Kimball J, Hubert B. Norman DJ, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1052-4. Transplant Proc. 1991. PMID: 1846453 No abstract available.

4

Renal consequences of a low dose cyclosporine triple therapy regimen in cardiac transplantation.

Bennett WM, Hosenpud J, Pantley G, Cobanoglu A, Starr A, Norman DJ. Bennett WM, et al. Among authors: norman dj. Transplant Proc. 1989 Feb;21(1 Pt 3):2479-80. Transplant Proc. 1989. PMID: 2650308 No abstract available.

5

OKT3-induced hypotension in heart allograft recipients treated for steroid-resistant rejection.

Hosenpud JD, Norman DJ, Pantely GA, Cobanoglu AM, Starr A. Hosenpud JD, et al. Among authors: norman dj. J Heart Transplant. 1989 Mar-Apr;8(2):159-65; discussion 165-6. J Heart Transplant. 1989. PMID: 2651620

6

Cyclosporine versus azathioprine in high risk cadaver kidney transplant recipients: a prospective randomized study.

Norman DJ, Wetzsteon P, Barry JM, Bennett WM. Norman DJ, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):1845. Transplant Proc. 1987. PMID: 3079046 Clinical Trial. No abstract available.

7

Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection.

Norman DJ, Shield CF 3rd, Henell KR, Kimball J, Barry JM, Bennett WM, Leone M. Norman DJ, et al. Transplantation. 1988 Oct;46(4):523-9. doi: 10.1097/00007890-198810000-00011. Transplantation. 1988. PMID: 3140448

8

HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used.

De Mattos AM, Head MA, Everett J, Hosenpud J, Hershberger R, Cobanoglu A, Ott G, Ratkovec R, Norman DJ. De Mattos AM, et al. Among authors: norman dj. Transplantation. 1994 Feb 27;57(4):626-30. Transplantation. 1994. PMID: 8116051

9

Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants.

Batiuk TD, Barry JM, Bennett WM, Meyer MM, Tolzman D, Norman DJ. Batiuk TD, et al. Among authors: norman dj. Transplant Proc. 1993 Feb;25(1 Pt 2):1391. Transplant Proc. 1993. PMID: 8382860 Clinical Trial. No abstract available.

10

Cytokine-related encephalopathy induced by OKT3: incidence and predisposing factors.

Shihab F, Barry JM, Bennett WM, Meyer MM, Norman DJ. Shihab F, et al. Among authors: norman dj. Transplant Proc. 1993 Feb;25(1 Pt 1):564-5. Transplant Proc. 1993. PMID: 8438415 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters